Farms.com Home   News

AgriStability September 30th Deadline Approaches

It’s that time of year again; time to think about filing the paperwork for the 2017 AgriStability program.
 
The program is administered through the Saskatchewan Crop Insurance Corporation and September 30th marks the first deadline.
 
SCIC says the information submitted on the form details the farm’s situation for the program year.
 
A farm’s coverage is based on the comparison between this program year information and a producer’s reference margin, which is the historical financial profile of the farm.
 
Benefits are generated when the farm’s program year falls below 70% of their reference margin.
 
If a producer does not file annually, there will be a gap in the information needed to build the reference margin and this will cause delays when processing future program forms.
 
Any 2017 program forms received after the September 30, 2018 deadline are subject to a penalty fee.
 
Source : Discoverestevan

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.